|
C6ORF106 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.79890000000005E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.16340000253257E-08 |
| Normal-vs-Stage2 |
4.417800E-01 |
| Normal-vs-Stage3 |
8.230000E-01 |
| Normal-vs-Stage4 |
6.828600E-01 |
| Stage1-vs-Stage2 |
5.724200E-02 |
| Stage1-vs-Stage3 |
5.842800E-03 |
| Stage1-vs-Stage4 |
2.481400E-01 |
| Stage2-vs-Stage3 |
4.672000E-01 |
| Stage2-vs-Stage4 |
9.623000E-01 |
| Stage3-vs-Stage4 |
6.190000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.876200000003E-05 |
| Normal-vs-AfricanAmerican |
2.337800E-03 |
| Normal-vs-Asian |
9.388400E-01 |
| Caucasian-vs-AfricanAmerican |
9.991600E-01 |
| Caucasian-vs-Asian |
4.748000E-01 |
| AfricanAmerican-vs-Asian |
4.791800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.76209999983124E-07 |
| Normal-vs-Female |
8.195400E-01 |
| Male-vs-Female |
1.780220E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.460200E-03 |
| Normal-vs-Extreme_Weight |
1.02749999952856E-07 |
| Normal-vs-Obese |
3.159600E-01 |
| Normal-vs-Extreme_Obese |
5.818000E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.149600E-01 |
| Normal_Weight-vs-Obese |
1.143580E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.668800E-01 |
| Extreme_Weight-vs-Obese |
1.721290E-03 |
| Extreme_Weight-vs-Extreme_Obese |
7.859700E-02 |
| Obese-vs-Extreme_Obese |
4.642000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.641200E-01 |
| Normal-vs-Age(41-60Yrs) |
2.202200E-03 |
| Normal-vs-Age(61-80Yrs) |
5.82309999996866E-07 |
| Normal-vs-Age(81-100Yrs) |
3.660100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.030970E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.666100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.908400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.240400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.554800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.928000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.01949999553597E-08 |
| Normal-VS-Type2 PRCC |
2.290000E-01 |
| Normal-VS-KIRP CIMP |
3.984400E-02 |
| Normal-VS-Unclassified PRCC |
8.999900E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.412120E-04 |
| Type1 PRCC-VS-KIRP CIMP |
5.936000E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
6.541300E-03 |
| Type2 PRCC-VS-KIRP CIMP |
2.536400E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
5.564000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.760440E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.341930E-02 |
| Normal-vs-N1 |
1.709810E-01 |
| Normal-vs-N2 |
7.091000E-01 |
| N0-vs-N1 |
1.915980E-02 |
| N0-vs-N2 |
5.406000E-01 |
| N1-vs-N2 |
4.918400E-01 |
|
|
